245
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Clinical Outcomes of Retinal Detachment Surgery following Cytomegalovirus Retinitis in Patients on Highly Active Anti-retroviral Therapy for Acquired Immune Deficiency Syndrome

, MS, , MS, DNB, FRCSEd, , MS & , MS
Pages 400-404 | Received 06 Mar 2014, Accepted 05 Dec 2014, Published online: 29 Jul 2015

References

  • Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264–271
  • Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623–683.a
  • Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 1996;114:821–827
  • Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397–408
  • Freeman WR, Henderly DE, Wan WL, et al. Prevalence, pathophysiology and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1987;103:527–536
  • Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997;124:227–233
  • Gallant JE, Moore RD, Richman DD, et al; Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223–1227
  • Biswas J, Madhavan HN, George AE, et al. Ocular lesions associated with HIV infection. Am J Ophthalmol. 2000;129:9–11
  • Davis JL. Management of CMV retinal detachments in the new era of antiretroviral therapy. JAMA. 2000; 283:653–657
  • Fenton KA, Valdiserri RO. Twenty-five years of HIV/AIDS—United States, 1981–2006. MMWR Morb Mortal Wkly Rep. 2006;55:585–589
  • Martidis A, Danis RP, Ciulla TA. Treating cytomegalovirus retinitis-related retinal detachment by combining silicon oil tamponade and ganciclovir implant. Ophthalmic Surg Lasers. 2002;33:135–139
  • Goldberg DE, Wang H, Azen SP, Freeman WR. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active anti-retroviral therapy. Br J Ophthalmol. 2003;87:853–855
  • Kempen JH, Jabs DA, Dunn JP, et al. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001;119:33–40
  • Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, et al. Studies of Ocular Complications of AIDS Research Group: course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy—second eye involvement and retinal detachment. Ophthalmology. 2004;111:2232–2239
  • Holbrook JT, Jabs DA, Weinberg DV, et al. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol. 2003;121:99–107
  • Jabs DA, Van Natta ML, Thorne JE, et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy—retinitis progression. Ophthalmology. 2004;111:2224–2231
  • Jabs DA. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2013;120:1262–1270
  • Thorne JE, Jabs DA, Kempen JH, et al. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006;113:1441–1445
  • Belfort R Jr. The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2000;129:1–8
  • Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med. 2001;164:7–12
  • Stier PA, Glazer LC, Garretson BR, et al. Surgical repair of retinal detachment secondary to cytomegalovirus retinitis. Ophthalmic Surg. 1999;30:289–294
  • Davis J, Serfass MS, Lai MY, et al. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol. 1995;113:1401–1409
  • Regillo CD, Vander JF, Duker JS, et al. Repair of retinitis related retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:21–27
  • Dugel PU, Liggett PE, Lee MB, et al. Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991;112:235–242
  • Freeman WR, Quiceno JI, Crapotta JA, et al. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992;99:466–474
  • Kuppermann BD, Flores-Aguilar M, Quiceno JI, et al. A masked prospective evaluation of outcome parameters for cytomegalovirus-related retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology. 1994;101:46–55
  • Davis JL, Serfass MS, Lai MY, et al. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol. 1995;113:1401–1409
  • Canzano JC, Morse LS, Wendel RT. Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS. Retina. 1999;19:274–280
  • Kunavisarut P, Bijlsma WR, Pathanapitoon K, et al. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2010;150:218–222
  • Morrison VL, Labree LD, Azen SP, et al. Results of silicon oil removal in patients with cytomegalovirus retinitis related retinal detachments. Am J Ophthalmol. 2005;140:786–793
  • Dave VP, Mathai A, Pappuru RR. Results of silicone oil removal in post-cytomegalovirus retinitis-related retinal detachment. J Ophthalmic Inflamm Infect. 2012;2:153–155
  • Singh R, Bhalekar S, Parchand S, et al. Outcome of surgery in post-cytomegalovirus retinal detachment: experience before and in the era of highly active anti-retroviral therapy in Indian eyes. Indian J Ophthalmol. 2013;61:636–639

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.